180 Life Sciences Corp. (ATNF)
USD 1.74
(-4.4%)
USD 1.74
(-4.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.92 Million | -12.12 Million | -19.37 Million | -3.87 Million | -3.31 Million | -3.91 Million |
| Net Income | -19.93 Million | -38.72 Million | -20.32 Million | -10.88 Million | -25.39 Million | -14.49 Million |
| Depreciation & Amortization | 105.67 Thousand | 109 Thousand | 109.94 Thousand | 125.33 Thousand | 72.24 Thousand | 23.07 Thousand |
| Deferred income taxes | -2.34 Million | -942.74 Thousand | -24.8 Thousand | -20.42 Thousand | -9496.00 | - |
| Stock-based compensation | 2.28 Million | 2.96 Million | 5 Million | 1.11 Million | 13.29 Million | 4.59 Million |
| Change in working capital | -14.1 Thousand | 2.72 Million | -8.8 Million | 2.33 Million | 3.03 Million | -117.52 Thousand |
| Other non-cash items | 9.07 Million | 22.07 Million | 6.82 Million | 3.45 Million | 5.67 Million | 6.07 Million |
| Investing Cash Flow | - | - | - | 14.49 Million | -708.14 Thousand | -90.82 Thousand |
| Investments in PPE | 3.00 | - | - | - | -144.4 Thousand | -30.82 Thousand |
| Acquisitions | - | - | - | 3 Million | 86.07 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 10.28 Million | - | - |
| Other Investing Activities | - | - | - | 1.2 Million | -649.82 Thousand | -60 Thousand |
| Financing Cash Flow | 5.9 Million | 10.87 Million | 25.41 Million | -8.73 Million | 3.94 Million | 4.76 Million |
| Debt repayment | -288.06 Thousand | -1.67 Million | -817.59 Thousand | -72.84 Thousand | -2.68 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.01 Million | - | -9 Million | - | - |
| Common Stock Issuance | 6.19 Million | 12.49 Million | 26.66 Million | 72.5 Thousand | 1.13 Million | - |
| Other Financing Activities | 195.95 Thousand | 1.06 Million | -436.68 Thousand | 747.67 Thousand | 5.49 Million | 4.76 Million |
| Accounts receivables | 56 Thousand | - | - | - | - | - |
| Accounts payables | 286.41 Thousand | 1.21 Million | -5.73 Million | 2.22 Million | 2.89 Million | 70.17 Thousand |
| Inventory | -230.4 Billion | - | - | - | - | - |
| Other working capital | 230.4 Billion | 1.5 Million | -3.07 Million | 105.35 Thousand | 140.98 Thousand | -117.52 Thousand |
| Cash at beginning of period | 6.97 Million | 8.22 Million | 2.1 Million | 83.39 Thousand | 567.22 Thousand | 428.39 Thousand |
| Cash at end of period | 1.97 Million | 6.97 Million | 8.22 Million | 2.1 Million | 83.39 Thousand | 270.88 Thousand |
| Capital Expenditure | 3.00 | - | - | - | -144.4 Thousand | -30.82 Thousand |
| Effect of forex changes on cash | 20.02 Thousand | -419.00 | 75.47 Thousand | 140.31 Thousand | -399.36 Thousand | -79.09 Thousand |
| Net cash flow / Change in cash | -4.99 Million | -1.25 Million | 6.11 Million | 2.02 Million | -483.82 Thousand | -157.5 Thousand |
| Free Cash Flow | -10.92 Million | -12.12 Million | -19.37 Million | -3.87 Million | -3.46 Million | -3.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.78 Thousand | -1.06 Million | -19.93 Million | -1.22 Million | -10.26 Million | -3.68 Million |
| Depreciation & Amortization | 23.98 Thousand | 23.57 Thousand | 105.67 Thousand | 22.66 Thousand | 32.69 Thousand | 28.55 Thousand |
| Deferred income taxes | - | - | -2.34 Million | -4658.00 | 2.57 Million | -11.6 Thousand |
| Stock-based compensation | 22.3 Thousand | 236.06 Thousand | 2.28 Million | 529.97 Thousand | 644.61 Thousand | 551.31 Thousand |
| Change in working capital | 826.27 Thousand | -223.5 Thousand | -14.1 Thousand | -1.47 Million | 1.09 Million | -2117.00 |
| Other non-cash items | -86.9 Thousand | 283.4 Thousand | 9.07 Million | 23.01 Thousand | 4.2 Million | -2811.00 |
| Investing Cash Flow | - | - | - | 4.21 Million | -4.85 Million | 640.39 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 4.21 Million | - | - |
| Financing Cash Flow | -264.9 Thousand | -264.39 Thousand | 5.9 Million | 1.46 Million | 2.44 Million | 2.46 Million |
| Debt repayment | -264.9 Thousand | -264.88 Thousand | -288.06 Thousand | -697.1 Thousand | -257.63 Thousand | -257.73 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 489.00 | 6.19 Million | 771.25 Thousand | 2.99 Million | 2.72 Million |
| Other Financing Activities | - | 489.00 | 195.95 Thousand | 770.92 Thousand | -294.91 Thousand | 2462.27 |
| Accounts receivables | - | - | 56 Thousand | -36.89 Thousand | - | - |
| Accounts payables | 284.54 Thousand | -309.79 Thousand | 286.41 Thousand | 334.35 Thousand | 928.43 Thousand | -354.51 Thousand |
| Inventory | - | - | -230.4 Billion | -329.41 Thousand | - | - |
| Other working capital | 826.27 Thousand | -223.5 Thousand | 230.4 Billion | -1.8 Million | 168.59 Thousand | 352.4 Thousand |
| Cash at beginning of period | 675.97 Thousand | 1.97 Million | 6.97 Million | 2.66 Million | 2 Million | 2.64 Million |
| Cash at end of period | 1.14 Million | 675.97 Thousand | 1.97 Million | 1.97 Million | 2.66 Million | 2 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 8049.00 | -2011.00 | 20.02 Thousand | 4932.00 | -17.67 Thousand | 16.99 Thousand |
| Net cash flow / Change in cash | 470.31 Thousand | -1.29 Million | -4.99 Million | -686.72 Thousand | 653.91 Thousand | -637.57 Thousand |
| Free Cash Flow | 727.17 Thousand | -1.03 Million | -10.92 Million | -2.16 Million | -1.77 Million | -3.11 Million |
MCKPA
004540
SILXF
HHDS
WHRL3
FLST